ASHLEY PETERSEN: Open Payments
NPI 1356025886 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$399 in 21 payments from 5 companies in 2025. Trend: 2023 $155 · 2024 $342 · 2025 $399
Food & beverage: $399
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $161 |
| Astellas Pharma US Inc | 3 | $91 |
| Biogen, Inc. | 3 | $70 |
| MAYNE PHARMA COMMERCIAL LLC | 5 | $53 |
| Organon LLC | 1 | $24 |
Products named: Veozah, ZURZUVAE, QULIPTA, VRAYLAR, UBRELVY, NEXPLANON.
Industry payments across NE — which companies pay providers there.
